Difference between revisions of "Sorafenib Dosing Nomogram"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - ":Section editor transclusions|" to ":Editorial board transclusions|")
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
−
{{#lst:Section editor transclusions|peds}}
+
{{#lst:Editorial board transclusions|peds}}
−
<big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow [[Acute myeloid leukemia|this link]].</big>
 
 
{| class="wikitable" style="float:right; margin-right: 5px;"
 
{| class="wikitable" style="float:right; margin-right: 5px;"
 
|-
 
|-
Line 8: Line 7:
 
{{TOC limit|limit=3}}
 
{{TOC limit|limit=3}}
  
−
=AAML1031 Sorafenib Dosing Nomogram==
+
=AAML1031 Sorafenib Dosing Nomogram=
−
 
+
''Note: BSA is rounded to the hundredth place.''
−
{| class="wikitable" style="width: 40%; text-align:center;"  
+
{| class="wikitable" style="width: 80%; text-align:center;"  
 
! style="width: 25%" |BSA Range (m<sup>2</sup>)
 
! style="width: 25%" |BSA Range (m<sup>2</sup>)
 
! style="width: 25%" |Dose Level 0 (100 mg/m<sup>2</sup>/day once daily)
 
! style="width: 25%" |Dose Level 0 (100 mg/m<sup>2</sup>/day once daily)
 
! style="width: 25%" |Dose Level 1 (200 mg/m<sup>2</sup>/day once daily)
 
! style="width: 25%" |Dose Level 1 (200 mg/m<sup>2</sup>/day once daily)
−
! style="width: 25%" |Dose Level 2 (300 mg/m<sup>2</sup>/day divided BID)
+
! style="width: 25%" |Dose Level 2 (300 mg/m<sup>2</sup>/day divided twice per day)
 
|-
 
|-
−
|≤ 0.35
+
|Less than or equal to 0.35
 
|50 mg x 4 days/week,
 
|50 mg x 4 days/week,
 
0 x 3 day/week
 
0 x 3 day/week
Line 23: Line 22:
 
100 mg x 2 days/week
 
100 mg x 2 days/week
 
(450 mg)
 
(450 mg)
−
|50 mg twice daily x 7 days/week
+
|50 mg twice per day x 7 days/week
 
(700 mg)
 
(700 mg)
 
|-
 
|-
−
|0.36 - 0.4
+
|0.36 to 0.40
 
|50 mg x 5 days/week,
 
|50 mg x 5 days/week,
 
0 x 2 day/week
 
0 x 2 day/week
Line 33: Line 32:
 
100 mg x 3 days/week
 
100 mg x 3 days/week
 
(500 mg)
 
(500 mg)
−
|50 mg twice daily x 6 days/week +
+
|50 mg twice per day x 6 days/week +
−
100 mg twice daily x 1 day/week
+
100 mg twice per day x 1 day/week
 +
(800 mg)
 +
|-
 +
|0.41 to 0.45
 +
|50 mg x 6 days/week,
 +
0 x 1 day/week
 +
(300 mg)
 +
|50 mg x 2 days/week,
 +
100 mg x 5 days/week
 +
(600 mg)
 +
|50 mg twice per day x 5 days/week +
 +
100 mg twice per day x 2 days/week
 +
(900 mg)
 +
|-
 +
|0.46 to 0.55
 +
|50 mg x 7 days/week
 +
(350 mg)
 +
|100 mg x 7 days/week
 +
(700 mg)
 +
|50 mg q AM +100 mg q PM
 +
x 7 days/week
 +
(1050 mg)
 +
|-
 +
|0.56 to 0.60
 +
|50 mg x 6 days/week,
 +
100 mg x 1 day/week
 +
(400 mg)
 +
|100 mg x 6 days/week,
 +
200 mg x 1 day/week
 
(800 mg)
 
(800 mg)
 +
|50 mg twice per day x 2 days/week +
 +
100 mg twice per day x 5 days/week
 +
(1200 mg)
 +
|-
 +
|0.61 to 0.70
 +
|50 mg x 5 days/week,
 +
100 mg x 2 days/week
 +
(450 mg)
 +
|100 mg x 5 days/week,
 +
200 x 2 days/week
 +
(900 mg)
 +
|100 mg twice per day x 7 days/week
 +
(1400 mg)
 
|-
 
|-
−
 
+
|0.71 to 0.80
 +
|50 mg x4 days/week,
 +
100 mg x3 days/week
 +
(500 mg)
 +
|150 mg x 7 days/week
 +
(1050mg)
 +
|100 mg twice per day x 5 days/week +
 +
150 mg twice per day x 2 days/week
 +
(1600 mg)
 +
|-
 +
|0.81 to 0.90
 +
|50 mg x 2 days/week,
 +
100 mg x 5 days/week
 +
(600 mg)
 +
|150 mg x 4 days/week,
 +
200 mg x 3
 +
days/week
 +
(1200 mg)
 +
|100 mg q AM + 150 mg q PM
 +
x 7 days/week
 +
(1750 mg)
 +
|-
 +
|0.91 to 1.05
 +
|100 mg x 7 days/week
 +
(700 mg)
 +
|200 mg x 7 days/week
 +
(1400 mg)
 +
|150 mg twice per day x 7 days/week
 +
(2100 mg)
 +
|-
 +
|1.06 to 1.20
 +
|100 mg x 6 days/week,
 +
200 mg x1 day/week
 +
(800 mg)
 +
|200
 +
mg x 3 days/week,
 +
250 mg x 4 days/week
 +
(1600 mg)
 +
|150 mg q AM + 200 mg q PM
 +
x 7 days/week
 +
(2450 mg)
 +
|-
 +
|1.21 to 1.35
 +
|100 mg x 5 days/week,
 +
200 mg x 2 days/week
 +
(900 mg)
 +
|250 mg x 7 days/week
 +
(1750 mg)
 +
|200 mg twice per day x 7 days/week
 +
(2800 mg)
 +
|-
 +
|1.36 to 1.60
 +
|100 mg x 4 days/week,
 +
200 mg x 3 days/week
 +
(1000 mg)
 +
|300 mg x 7 days/week
 +
(2100 mg)
 +
|200 mg q AM + 250 mg q PM
 +
x 7 days/week
 +
(3150 mg)
 +
|-
 +
|1.61 to 1.70
 +
|100 mg x 2 days/week,
 +
200 mg x 5 days/week
 +
(1200 mg)
 +
|350 mg x 7 days/week
 +
(2450 mg)
 +
|250 mg twice per day x 7
 +
days/week
 +
(3500 mg)
 +
|-
 +
|1.71 to 1.85
 +
|100 mg x 1 day/week,
 +
200 mg x 6 days/week
 +
(1300 mg)
 +
|350 mg x 3 days/week
 +
400 mg x 4 days/week
 +
(2650 mg)
 +
|250 mg q AM + 300 mg q PM
 +
x 7 days/week
 +
(3850 mg)
 
|-
 
|-
 +
|1.86 or more
 +
|200 mg x 7 days/week
 +
(1400 mg)
 +
|400 mg x 7 days/week
 +
(2800 mg)
 +
|300 mg twice per day x 7 days /week
 +
(4200 mg)
 +
|}
  
−
|}
+
[[Category:General reference pages]]
 +
[[Category:Clinical pharmacology]]

Latest revision as of 20:21, 11 August 2023

Section editor
Noyd.png
 David Noyd, MD, MPH
University of Washington
Seattle, WA, USA
LinkedIn
0 regimens on this page
0 variants on this page


AAML1031 Sorafenib Dosing Nomogram

Note: BSA is rounded to the hundredth place.

BSA Range (m2) Dose Level 0 (100 mg/m2/day once daily) Dose Level 1 (200 mg/m2/day once daily) Dose Level 2 (300 mg/m2/day divided twice per day)
Less than or equal to 0.35 50 mg x 4 days/week,

0 x 3 day/week (200 mg)

50 mg x 5 days/week,

100 mg x 2 days/week (450 mg)

50 mg twice per day x 7 days/week

(700 mg)

0.36 to 0.40 50 mg x 5 days/week,

0 x 2 day/week (250 mg)

50 mg x 4 days/week,

100 mg x 3 days/week (500 mg)

50 mg twice per day x 6 days/week +

100 mg twice per day x 1 day/week (800 mg)

0.41 to 0.45 50 mg x 6 days/week,

0 x 1 day/week (300 mg)

50 mg x 2 days/week,

100 mg x 5 days/week (600 mg)

50 mg twice per day x 5 days/week +

100 mg twice per day x 2 days/week (900 mg)

0.46 to 0.55 50 mg x 7 days/week

(350 mg)

100 mg x 7 days/week

(700 mg)

50 mg q AM +100 mg q PM

x 7 days/week (1050 mg)

0.56 to 0.60 50 mg x 6 days/week,

100 mg x 1 day/week (400 mg)

100 mg x 6 days/week,

200 mg x 1 day/week (800 mg)

50 mg twice per day x 2 days/week +

100 mg twice per day x 5 days/week (1200 mg)

0.61 to 0.70 50 mg x 5 days/week,

100 mg x 2 days/week (450 mg)

100 mg x 5 days/week,

200 x 2 days/week (900 mg)

100 mg twice per day x 7 days/week

(1400 mg)

0.71 to 0.80 50 mg x4 days/week,

100 mg x3 days/week (500 mg)

150 mg x 7 days/week

(1050mg)

100 mg twice per day x 5 days/week +

150 mg twice per day x 2 days/week (1600 mg)

0.81 to 0.90 50 mg x 2 days/week,

100 mg x 5 days/week (600 mg)

150 mg x 4 days/week,

200 mg x 3 days/week (1200 mg)

100 mg q AM + 150 mg q PM

x 7 days/week (1750 mg)

0.91 to 1.05 100 mg x 7 days/week

(700 mg)

200 mg x 7 days/week

(1400 mg)

150 mg twice per day x 7 days/week

(2100 mg)

1.06 to 1.20 100 mg x 6 days/week,

200 mg x1 day/week (800 mg)

200

mg x 3 days/week, 250 mg x 4 days/week (1600 mg)

150 mg q AM + 200 mg q PM

x 7 days/week (2450 mg)

1.21 to 1.35 100 mg x 5 days/week,

200 mg x 2 days/week (900 mg)

250 mg x 7 days/week

(1750 mg)

200 mg twice per day x 7 days/week

(2800 mg)

1.36 to 1.60 100 mg x 4 days/week,

200 mg x 3 days/week (1000 mg)

300 mg x 7 days/week

(2100 mg)

200 mg q AM + 250 mg q PM

x 7 days/week (3150 mg)

1.61 to 1.70 100 mg x 2 days/week,

200 mg x 5 days/week (1200 mg)

350 mg x 7 days/week

(2450 mg)

250 mg twice per day x 7

days/week (3500 mg)

1.71 to 1.85 100 mg x 1 day/week,

200 mg x 6 days/week (1300 mg)

350 mg x 3 days/week

400 mg x 4 days/week (2650 mg)

250 mg q AM + 300 mg q PM

x 7 days/week (3850 mg)

1.86 or more 200 mg x 7 days/week

(1400 mg)

400 mg x 7 days/week

(2800 mg)

300 mg twice per day x 7 days /week

(4200 mg)

Retrieved from "https://hemonc.org/w/index.php?title=Sorafenib_Dosing_Nomogram&oldid=76301"